CellInsight Discovery Platform
Different patients with the same pathology do not respond to drugs in the same way. The industry is moving away from a one-size-fits-all approach to more personalized medicine, but to achieve that objective, a deeper insight into biological systems is necessary. CellMade developed a Translational Medicine approach via building multi-disciplinary teams enabling for more innovative biomarker and compound discovery. Within CellMade we have brought together a multi-disciplinary team from cell biologists, analytical chemists to bioinformatics specialists in an attempt to achieve a better understanding of biological systems.
CellMade developed its proprietary technology platform CellInsight linking tissue acquisition activities, cell production and characterization, development of ex vivo 3D models with an innovative analytical approach being cytometry coupled to (off-line) mass spectrometry.
CellMade’s trusted technology and expertise is dedicated to metabolic research efforts in many ways. CellInsight enables to define and design a comprehensive biomarker strategy.
- Biobank: define specific tissue sourcing projects;
- Cell Models: use CellInsight normal and disease human primary cells;
- Cellular Engineering: use CellInsight advanced 3D and coculture cell models;
- Defined in vitro and ex vivo Study Models within specialized therapeutic areas;
- Comprehensive portfolio of assays:
o >100 Functional assays
o >25 Profiling assays
o 1 NASH experimental biomarker
20, impasse des Sources